Operating Income (Loss) in USD of Sensei Biotherapeutics, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sensei Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2020 to Q3 2025.
  • Sensei Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$4.85M, a 38% increase year-over-year.
  • Sensei Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$25.6M, a 21.2% increase year-over-year.
  • Sensei Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$32.6M, a 12% increase from 2023.
  • Sensei Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$37.1M, a 26.2% increase from 2022.
  • Sensei Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.2M, a 33.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Sensei Biotherapeutics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$25.6M -$4.85M +$2.97M +38% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$28.6M -$5.21M +$2.58M +33.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 -$31.2M -$7.27M +$1.46M +16.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 -$32.6M -$8.27M -$132K -1.62% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$32.5M -$7.82M -$86K -1.11% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$32.4M -$7.79M +$2.39M +23.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 -$34.8M -$8.73M +$2.28M +20.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 -$37.1M -$8.14M +$4.91M +37.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$42M -$7.74M +$6.2M +44.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$48.2M -$10.2M +$535K +4.99% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$48.7M -$11M +$1.48M +11.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$50.2M -$13M -$3.64M -38.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$46.6M -$13.9M -$3.63M -35.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$42.9M -$10.7M -$928K -9.49% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$42M -$12.5M -$4.52M -56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$37.5M -$9.41M -$4.34M -85.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$33.1M -$10.3M -$4.95M -92.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$28.2M -$9.78M -$4.88M -99.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$23.3M -$7.97M -$3.87M -94.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$19.5M -$5.08M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$5.36M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.91M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$4.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13

Sensei Biotherapeutics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$32.6M +$4.45M +12% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$37.1M +$13.1M +26.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 -$50.2M -$12.7M -33.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$37.5M -$18M -92.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$19.5M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.